Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions

Details 詳細情報について

• CRID

  1360294647596044672

• DOI

  10.3389/fimmu.2020.00501

• ISSN

  16643224

• Web Site

  https://www.frontiersin.org/article/10.3389/fimmu.2020.00501/full

• Data Source

  • Crossref